A first glimpse of the human brain’s waste clearance system
A new non-invasive MRI technique provides a near-real-time view of the human brain’s waste-clearance system. …
Aging impairs anti-tumor T-cell response via mitochondria dysfunction
New research has shown that ceramide signaling mediates aging-dependent mitochondrial dysfunction, which inhibits anti-tumor T cell response. …
New vitamin K-based drug shows promise against medication-resistant epilepsy
A vitamin K-based compound eliminates medication-resistant epileptic seizures in mice. …
Elevated levels of advanced glycation end-products (AGEs) linked to breast cancer risk
Higher intake of advanced glycation end-products (AGEs) linked to increased risk of breast cancer. …
Natural antioxidant helps improve immune-based therapies by modulating T-cells
Researchers have discovered a way to improve immune-based treatments by modulating T-cells with thioredoxin, …
Potential new therapy takes aim at a lethal esophageal cancer’s glutamine addiction
Researchers have found a way to target drug-resistant esophageal cancer cells by exploiting the different energy needs of cancerous versus healthy cells. …
Antibiotic disruption of the gut microbiome dysregulates skeletal health
Microbes are often seen as pathogens that cause disease and antibiotics have been used successfully to combat these foreign invaders. In reality, the picture is …
Breaking down AGEs: Insight into how lifestyle drives ER-positive breast cancer
Poor diet and lack of exercise are associated with cancer development, but the underlying biology is not well understood. Advanced glycation end products (AGEs) …
Can a simple blood test rule out lung cancer?
Every year, health care providers in the United States discover more than 1.6 million lung nodules in patients. Many are “incidentally detected,” meaning they are found during evaluation for an unrelated cause …
New immunotherapy for lung cancer shows promise of success
In a groundbreaking development, results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at controlling the disease’s progression. …
End of content
End of content